Arsinothricin Biosynthesis Involving a Noncanonical Radical SAM Enzyme for C-As Bond Formation

Yadi Yao,Jiale He,Min Dong
DOI: https://doi.org/10.1101/2024.02.01.577332
2024-02-02
Abstract:Arsinothricin is a potent antibiotic secreted by soil bacteria. The biosynthesis of Arsinothricin was proposed to involve two steps. The first step is C-As bond formation between trivalent As and the 3-amino-3-carboxypropyl (ACP) group of S-adenosyl-L-methionine (SAM), which is catalyzed by the protein ArsL. However, the reaction has not been verified in vitro, and ArsL has not been characterized in detail. Interestingly, ArsL contains a CxxxCxxC motif and thus belongs to the radical SAM enzyme superfamily, the members of which cleave SAM and generate a 5′-deoxyadenosyl radical. Here, we found that ArsL cleaves the C –S bond of SAM and generates an ACP radical that resembles Dph2, a noncanonical radical SAM enzyme involved in diphthamid biosynthesis. As Dph2 does not contain the CxxxCxxC motif, ArsL is a unique noncanonical radical SAM enzyme that contains this motif but generates an ACP radical. Together with the methyltransferase ArsM, we successfully reconstituted arsinothricin biosynthesis in vitro. ArsL has a conserved RCCLKC motif in the C-terminal sequence and belongs to the RCCLKC-tail radical SAM protein subfamily. By truncation, we showed that this motif binds to the substrate arsenite and is highly important for its activity. Our results suggested that ArsL is a noncanonical radical SAM enzyme with a canonical radical SAM enzyme motif, implying that more noncanonical radical SAM chemistry may exist within the radical SAM enzyme superfamily.
Biochemistry
What problem does this paper attempt to address?
This paper mainly discusses the biosynthetic pathway of Arsinothricin, a potent antibiotic secreted by soil bacteria, particularly focusing on the role of the atypical kinase SAM enzyme ArsL. The biosynthesis of Arsinothricin involves a two-step process. The first step is the transfer of the 3-amino-3-carboxypropyl (ACP) group from SAM (S-adenosyl-L-methionine) to arsenate, forming a C-As bond. This reaction is catalyzed by ArsL but has not been verified in vitro. It was found that ArsL belongs to the superfamily of kinase SAM enzymes containing the CxxxCxxC motif. Usually, enzymes of this kind cleave SAM to produce a 5'-adenosyl radical. However, instead of generating a 5'-adenosyl radical, ArsL cleaves the Cγ,Me-S bond of SAM, similar to the atypical kinase SAM enzyme Dph2, to produce an ACP radical similar to that of Dph2. In collaboration with the methyltransferase ArsM, researchers successfully reconstructed the biosynthetic process of Arsinothricin in vitro. Experiments have shown that, in the presence of a reducing agent, ArsL effectively converts SAM into MTA (S-adenosylhomocysteine), and in conjunction with As(III) (trivalent arsenic), AST-OH (trivalent Arsinothricin) can be generated. The C-terminal RCCLKC motif of ArsL has been demonstrated to be essential for binding As(III) and its activity. By comparing different reducing agents, the study also revealed the specificity of ArsL in As(III) binding and its impact on C-As bond formation. These findings suggest that ArsL is an atypical kinase SAM enzyme with the conserved motifs of typical kinase SAM enzymes, but it performs atypical chemical reactions. This implies that there may be more unrecognized atypical kinase SAM enzyme chemistries within the superfamily of kinase SAM enzymes. Moreover, the discovery of ArsL is significant for understanding how microorganisms transform inorganic arsenic and for developing new antibiotic strategies.